Novoxel Ltd. is renowned for its groundbreaking technology and allocates many resources towards R&D, Intellectual Property and relentless protection of its Intellectual Property rights.
Intellectual Property protection that promotes innovation is central to fulfilling Novoxel®’s mission to offer a better aesthetic dermatologic treatment experience for the benefit of patients and doctors.
Accordingly, Novoxel globally employs a strong intellectual property strategy with a vast portfolio, including but not limited to patents and designs, that support, protect and promote innovation. The protection afforded by strong patents and designs allows Novoxel the readiness to publicly disclose information about its inventions.
The products listed on this website, either alone or in combination with other product(s), are protected by one or more of patents and/or designs. Additional patents and/or designs may be issued and/or pending in the United States or elsewhere.
.
TERRITORY | PATENT NUMBER |
---|---|
USA | US 9,402,678 B2 |
USA | US 10,327,832 B2 |
USA | US 10,702,328 B2 |
USA | US 11,083,515 B2 |
USA | US 11,291,498 B2 |
USA | US 11,439,455 B2 |
European Union | EP 2 459 092 B1 |
European Union | EP 3 193 761 B1 |
European Union | EP 3 082 634 B1 |
Israel | 217734 |
Israel | 251150 |
Israel | 246267 |
Israel | 278403 |
Israel | 279617 |
Israel | 279618 |
Israel | 267166 |
Japan | P5774001 |
Japan | 2012-522334 |
Japan | 2019-552858 |
Japan | 2020-017872 |
China | ZL 2014 8 0074496.5 |
China | ZL 2015 8 0061055.6 |
China | ZL 2018 8 0025322.8 |
South Korea | 10-2170876 |
South Korea | 10-2329660 |
South Korea | 10-2019-7031899 |
South Korea | 10-2020-7029933 |
TERRITORY | DESIGN NUMBER |
---|---|
European Union | 004426294-0001 |
China | ZL 201830172839.2 |
Korea | 30-1000646 |
Korea | 30-1027344 |
China | ZL 201830301704.1 |
European Union | 005307576-0001 005307576-0002 005307576-0003 |
USA | D903132 S D903133 S |
The United Kingdom | 90044262940001 90053075760001 90053075760002 90053075760003 |
Novoxel believes in firm and effective trademark protection. Thus not only patients and professional distributors, but also the public, rely upon trademarks to indicate uncompromising levels of trusted quality, high standards and safety.
Accordingly, Novoxel believes that strict trademark registration and relentless enforcing of its Intellectual Property rights are essential, not only to enable confident commercial decisions and encourage fair competition, but also to protect the health and safety of patients worldwide.
Trademarks must therefore be used properly. As such, please follow these guidelines for legally permitted use of Novoxel’s trademarks in all communications, documents and electronic messages. Third-party use of Novoxel’s trademarks requires a specific license or prior written permission from Novoxel.
You may refer to Novoxel products and services by their associated Novoxel trademarks as long as such references are truthful, fair and not misleading, and comply with the following guidelines:
Please note that such guidelines may be modified by Novoxel from time to time at Novoxel's sole discretion.